LONG MINI-FUTURE - NOVARTIS N Share Price

Certificat

INOAAZ

CH0506982096

Market Closed - Swiss Exchange 16:20:00 10/05/2024 BST
2.91 CHF +4.68% Intraday chart for LONG MINI-FUTURE - NOVARTIS N
Current month+8.58%
1 month+20.25%
Date Price Change Volume
10/05/24 2.91 +4.68% 0
08/05/24 2.78 +2.58% 0
07/05/24 2.71 +3.83% 0
03/05/24 2.61 -2.25% 0
02/05/24 2.67 -0.37% 0

Delayed Quote Swiss Exchange

Last update May 10, 2024 at 04:20 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
Issuer ZKB
INOAAZ
ISINCH0506982096
Date issued 13/03/2020
Strike 55.23 CHF
Maturity Unlimited
Parity 15 : 1
Emission price 0.94 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 2.91 CHF
Lowest since issue 0.96 CHF
Spread 0.01 CHF
Spread %0.34%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
99.69 USD
Average target price
108.4 USD
Spread / Average Target
+8.78%
Consensus
  1. Stock Market
  2. Certificates
  3. INOAAZ Certificat